عنوان مقاله :
مقايسه اثر دو رژيم سفتري اكسـون و سفازولين در درمان پيلونفريت حاد بالغين
عنوان به زبان ديگر :
Comparison of the Effects of Ceftriaxone and Cefazolin Regimes in the Treatment of Adult Acute Pyelonephritis
پديد آورندگان :
-، - گردآورنده - Ebrahimzadeh, A
اطلاعات موجودي :
فصلنامه سال 1388 شماره 52
كليدواژه :
مقاومت دارويي , پيلونفريت , درمان , سفازولين , سفتري اكسون
چكيده لاتين :
There have been variations on the response rate of microorganisms causing pyelonephritis to antibiotics in different studies. The present study was conducted to compare the drug resistance against Ceftriaxone and Cefazolin in adult acute pyelonephritis.
Methods and Materials: In this phase-3 single blind clinical trial, 86 patients suffering from pyelonephritis were selected through successive sampling, and were randomly assigned into one of the two groups after they signed an informed consent: Ceftriaxone 1g every 12 hours and IV Cefazolin 1g every 8 hours. Seventy two hours after the onset of treatment, patients were examined for their clinical and laboratory resistance. The obtained data were analyzed in SPSS using chi-square test, independent sample t-test, and Kappa coefficient. Results: Mean fever alleviation time were 2.63±0.95 and 2.77±0.81 days in the ceftriaxone and cefazolin groups respectively (p=0.2). Urinary culture 72 hours after treatment was positive in 7% of patients in both groups. In the ceftriaxone group, 51.2% of the patients were sensitive clinically and in the laboratory results. In total, 9.3% were sensitive in laboratory and clinically resistant; and 39.5% were sensitive in laboratory despite being clinically resistant. With the cefazolin group, 51.2% were both clinically and laboratory sensitive; and 7% were clinically and laboratory resistant; also, 11.6% were sensitive in laboratory but clinically resistant; but 30.2% were clinically sensitive despite being resistant in the laboratory results.
Conclusion: In the treatment of non-complicated upper urinary infections, the therapeutic effect of cefazolin is not different from that of ceftriaxone, which is broad spectrum and more expensive.
(Quarterly Journal of Sabzevar University of Medical Sciences, Volume 16, Number 2, pp.79-86).
عنوان نشريه :
فصلنامه دانشگاه علوم پزشكي و خدمات بهداشتي درماني سبزوار
عنوان نشريه :
فصلنامه دانشگاه علوم پزشكي و خدمات بهداشتي درماني سبزوار
اطلاعات موجودي :
فصلنامه با شماره پیاپی 52 سال 1388
كلمات كليدي :
#تست#آزمون###امتحان